Literature DB >> 23683786

RNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathway.

Jiang Cao1, Li Li, Chong Chen, Chao Lv, Fanjing Meng, Lingyu Zeng, Zhenyu Li, Qingyun Wu, Kai Zhao, Bin Pan, Hai Cheng, Wei Chen, Kailin Xu.   

Abstract

NANOG is critical for maintaining the self-renewal and proliferative properties of embryonic stem cells. Here we found that cultured T-cell acute lymphoblastic leukemia (T-ALL) cells, as well as human primary T-ALL cells, express a functional variant of NANOG. NANOG mRNA is derived predominantly from a retrogene locus termed NANOGP8. Furthermore, we showed that RNA interference-mediated NANOG knockdown inhibited cell proliferation, reduced self-renewal, promoted apoptosis and arrested the cell cycle through a p53-mediated pathway in leukemic cells. These findings demonstrate the oncogenic potential of this pluripotent gene in human T-ALL cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NANOG; T-cell acute lymphoblastic leukemia; p53

Mesh:

Substances:

Year:  2013        PMID: 23683786     DOI: 10.1016/j.leukres.2013.04.021

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

Review 1.  Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.

Authors:  Collene R Jeter; Tao Yang; Junchen Wang; Hsueh-Ping Chao; Dean G Tang
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

2.  An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.

Authors:  Joan P Breyer; Daniel C Dorset; Travis A Clark; Kevin M Bradley; Tiina A Wahlfors; Kate M McReynolds; William H Maynard; Sam S Chang; Michael S Cookson; Joseph A Smith; Johanna Schleutker; William D Dupont; Jeffrey R Smith
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

3.  Inhibition of NANOG/NANOGP8 downregulates MCL-1 in colorectal cancer cells and enhances the therapeutic efficacy of BH3 mimetics.

Authors:  Abid R Mattoo; Jingyu Zhang; Luis A Espinoza; J Milburn Jessup
Journal:  Clin Cancer Res       Date:  2014-09-10       Impact factor: 12.531

4.  MYC Regulates the HIF2α Stemness Pathway via Nanog and Sox2 to Maintain Self-Renewal in Cancer Stem Cells versus Non-Stem Cancer Cells.

Authors:  Bikul Das; Bidisha Pal; Rashmi Bhuyan; Hong Li; Anupam Sarma; Sukanya Gayan; Joyeeta Talukdar; Sorra Sandhya; Seema Bhuyan; Gayatri Gogoi; Arvin M Gouw; Debabrat Baishya; Jason R Gotlib; Amal C Kataki; Dean W Felsher
Journal:  Cancer Res       Date:  2019-07-02       Impact factor: 12.701

Review 5.  Insights into the Nanog gene: A propeller for stemness in primitive stem cells.

Authors:  Wei Zhang; Yi Sui; Jun Ni; Tao Yang
Journal:  Int J Biol Sci       Date:  2016-10-25       Impact factor: 6.580

6.  miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway.

Authors:  Dan-Dan Xu; Peng-Jun Zhou; Ying Wang; Yi Zhang; Rong Zhang; Li Zhang; Su-Hong Chen; Wu-Yu Fu; Bi-Bo Ruan; Hai-Peng Xu; Chao-Zhi Hu; Lu Tian; Jin-Hong Qin; Sheng Wang; Xiao Wang; Qiu-Ying Liu; Zhe Ren; Xue-Kui Gu; Yao-He Li; Zhong Liu; Yi-Fei Wang
Journal:  Front Pharmacol       Date:  2016-11-18       Impact factor: 5.810

7.  HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6.

Authors:  Shuangshuang Li; Xianqing Jin; Huan Wu; Yi Wang; Xiaoqing Li; Yuxia Guo; Shaoyan Liang
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

8.  NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.

Authors:  Xia Ma; Bei Wang; Xiaofang Wang; Yujiao Luo; Wufang Fan
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

Review 9.  Cycling to Meet Fate: Connecting Pluripotency to the Cell Cycle.

Authors:  Lamuk Zaveri; Jyotsna Dhawan
Journal:  Front Cell Dev Biol       Date:  2018-06-19

Review 10.  Drugs under preclinical and clinical study for treatment of acute and chronic lymphoblastic leukemia.

Authors:  Joe Antony Jacob; Jumah Masoud Mohammad Salmani; Baoan Chen
Journal:  Patient Prefer Adherence       Date:  2016-06-20       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.